[BGLC] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
31-May-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -638.48%
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 9,771 10,929 13,363 11,390 127 212 108 111.80%
PBT -2,608 -304 1,043 1,263 -276 60 -119 67.24%
Tax 22 52 291 168 -29 33 4 32.84%
NP -2,629 -356 752 1,094 -246 26 -124 66.32%
Tax Rate - - -27.93% -13.34% - -55.84% - -
Total Cost 12,400 11,285 12,611 10,296 373 186 231 94.16%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -26.91 -3.26 5.62 9.61 -194.14 12.46 -114.92 -21.48%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.17 -0.02 0.05 0.13 -0.03 0.00 -0.02 42.83%
EPS Diluted -0.17 -0.02 0.05 0.13 -0.03 0.00 -0.02 42.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.